| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc06cad2b58bbfcc30e3c96a6eb6c926 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D325-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate |
2011-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ce047f4e38c1ad598dadb852aae713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_feb591075bf58401ed15824920ca4b13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a775383fae62d08b54a990c0c8b993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146ccd02a55985190fc0d7fd76cf8759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca18b89edabbeac8fe7bc991610b52dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34d732c598d48dd57c71efdcda2d487d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a23b041709f42f1a394f33fb447c093 |
| publicationDate |
2012-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201231051-A |
| titleOfInvention |
Anti-bacterial infection, inflammation, and leukemia composition and use thereof |
| abstract |
The present invention is related to a composition which comprises Tellimagrandin II and a β -lactam antibiotic or a polyketide antibiotic. The present invention also provides a use of Tellimagrandin II for the manufacture of a medicament for use in treatment of Methicillin-resistant Staphylococcus aureus infection. Besides, Tellimagrandin II provides as a medicament for biofilm prevention of Staphylococcus aureus. The present invention further provides a use of Tellimagrandin II for the manufacture of a medicament for use in treatment of sepsis. In addition, the present invention further provides a use of Tellimagrandin II for the manufacture of a medicament for use in treatment of leukemia. |
| priorityDate |
2011-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |